立体定向放射外科治疗残余或复发性垂体腺瘤的效果:系统综述与Meta分析
该系统综述与Meta分析纳入26项研究共2315例患者,评估立体定向放射外科对残余或复发性垂体腺瘤的疗效与并发症。平均随访57.8个月,平均辐射边缘剂量19.6 Gy,总体肿瘤控制率95%、肿瘤缩小率46%、激素控制率67%。作者认为立体定向放射外科对残余或复发性肿瘤控制有效且副作用少,推荐用于分泌型和非分泌型残余或复发性肿瘤。
要点
- 立体定向放射外科治疗残余或复发性垂体腺瘤的总体肿瘤控制率为95%。
- 肿瘤缩小率为46%,激素控制率为67%。
- 作者推荐立体定向放射外科用于分泌型和非分泌型残余或复发性肿瘤。
核心结论
- 立体定向放射外科对残余或复发性肿瘤控制有效且副作用少,推荐用于治疗分泌型和非分泌型残余或复发性肿瘤。
研究设计与样本
- 按PRISMA声明标准对MEDLINE/PubMed、Cochrane Central Database和Google Scholar进行系统文献综述,检索按PICOT策略构建,方法学质量(偏倚风险)按MINORS量表评估,数据提取后用R软件分组分析,共纳入26篇文章2315例患者。
主要发现
- 平均随访57.8个月,平均辐射边缘剂量19.6 Gy。
- 总体肿瘤控制率为95%,肿瘤缩小率为46%,激素控制率为67%。
- 对副作用进行了评估。
临床怎么用
- 作者认为立体定向放射外科对残余或复发性肿瘤控制有效且副作用少,推荐用于治疗分泌型和非分泌型残余或复发性肿瘤。
局限性
- 本研究的局限性在于合成分析中未纳入随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In pituitary tumors, the presence of residual tumor after transsphenoidal surgery and recurrence of the tumor after resection are frequent, and the best treatment is not well established. The effects and complications of stereotactic radiosurgery have not been extensively studied. OBJECTIVE: We aimed to reveal the effect of stereotactic radiosurgery on residual and recurrent adenomas. METHODS: A systematic review of the literature in the MEDLINE/PubMed, Cochrane Central Database, and Google Scholar was conducted using the criteria of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. The search was structured according to the PICOT (i.e., Participants, types of Interventions, Comparator between the treatments, types of Outcome measures, and Follow-up [Time of duration]) strategy. The methodologic quality assessment (risk of bias) was performed according to the Methodological Index for Non-Randomized Studies scale. The studies were grouped and analyzed after data extraction using the software "R". RESULTS: Twenty-six articles including 2315 patients were analyzed, with an average follow-up duration of 57.8 months and mean radiation marginal dose of 19.6 Gy. The overall tumor control rate was 95%, tumor reduction rate was 46%, and hormonal control rate was 67%. The side effects were evaluated. CONCLUSIONS: Stereotactic radiosurgery was efficient in residual or recurrence tumor control, with few side effects, and is recommended for treating residual or recurrent tumors, both secreting and nonsecreting tumors. A limitation of this study is that there were no randomized trials included in the synthesis.
引用
- Heringer LC, Machado de Lima M, Rotta JM, et al. Effect of Stereotactic Radiosurgery on Residual or Relapsed Pituitary Adenoma: A Systematic Review and Meta-Analysis. World Neurosurg. 2019. PMID: 31899390. doi:10.1016/j.wneu.2019.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。